In addition, albumin level in both BCL-2 and BCL-6 negative groups had no effect on the prognosis of DLBCL patients (P = 0.170, P = 0.054), while different albumin level in BCL-2 and BCL-6 positive groups had influence on the prognosis (P < 0.001, Figures 5C, D). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.